Stifel Maintains Hold on Core Laboratories, Raises Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Stephen Gengaro maintains a Hold rating on Core Laboratories (NYSE:CLB) and raises the price target from $17 to $18.
April 26, 2024 | 3:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel maintains a Hold rating on Core Laboratories and raises the price target from $17 to $18.
The increase in price target by Stifel suggests a positive outlook on the stock's value, potentially leading to increased investor interest and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 90